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appear that a porcine heterograft prosthesis with addi- 
tional anticoagulation would be beneficial. However, the 
toxic effects of eosinophilic granules on the xenograft 
remain to be evaluated. At autopsy in one such patient 
(Harley and colleagues2), although there were no mural 
thrombi, small thrombi were present on the bioprostheses 
despite treatment with warfarin. 
Review of the literature 4 further suggests that the 
exacerbations of symptoms in these patients, as in ours, 
should be treated with prednisolone 1 mg/kg and hydroxy 
urea 500 mg daily. Once the endocarditis  under control 
and remission of systemic symptoms has occurred, oper- 
ation should be planned for relief of cardiac symptoms. 
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A DEHYDROMONOCROTALINE-INDUCED PULMONARY HYPERTENSION MODEL 
IN THE BEAGLE 
Morihito Okada, MD, Chojiro Yamashita, MD, Masayoshi Okada, MD, and Kenji Okada, MD, Kobe, Japan 
Pulmonary hypertension (PH) is a poorly understood 
disease process for which no adequate therapy exists. 
Trials to gain a better understanding of PH have been 
hindered by the lack of relevant animal models. Although 
monocrotaline and hypoxia have both been used to gen- 
erate PH in rats, 1' 2 rats are too small to allow hemody- 
namics to be evaluated accurately. We therefore tried to 
establish a model of PH in a larger animal, the beagle. 
However, a homogeneous model could not be produced 
in dogs by the administration of monocrotaline or by 
the long-term exposure to hypoxia. It is considered that 
monocrotaline is activated to a reactive metabolite in the 
liver and is then transported by red blood cells to the lung, 
where it initiates endothelial injury. The difference re- 
garding the effect of monocrotaline on the lung between a
rat and a dog, which might be due to the hepatic metabolic 
system, encouraged us to examine the reactive hepatic 
metabolites. The purpose of this study was to evaluate the 
cardiopulmonary hemodynamic alterations that devel- 
oped in beagles after the direct administration of dehy- 
dromonocrotaline (DMCT), a putative toxic metabolite of 
monocrotaline, which was made in vitro. 
Twenty purebred beagles with a mean age of 3 months 
and weighing 4 to 6 kg were used for the study. DMCT 
was prepared as described by Mattocks 3and was dissolved 
in dimethylformamide just before injection. After the 
baseline hemodynamics were measured, a single injection 
of DMCT, 1.5 mg/kg (n = 7), 3 mg/kg (n = 10), or 4.5 
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mg/kg (n = 3), was performed. Hemodynamic data and 
blood samples were obtained 8weeks after injection. For 
each hemodynamic measurement, the beagles were anes- 
thetized with sodium pentobarbital (25 mg/kg intrave- 
nously) and permitted to breathe spontaneously. Under 
stable conditions, a Swan-Ganz catheter (Baxter Health- 
care Corporation, Edwards Div., Santa Ana, Calif.) was 
placed from the femoral vein to the pulmonary artery for 
measurement of pressure in the right side of the heart, 
and another catheter was placed in the femoral artery for 
measurement of systemic pressure. So that the weight 
ratio of the right to left ventricle could be calculated, the 
interventricular septum was included with the left ventri- 
cle. Portions of each lung and right ventricle were fixed, 
cut, and stained for histologic study. All animals received 
humane care in compliance with the "Principles of Lab- 
oratory Animal Care" formulated by the National Society 
for Medical Research and the "Guide for the Care and 
Use of Laboratory Animals" prepared by the Institute of 
Laboratory Animal Resources and published by the Na- 
tional Institutes of Health (NIH Publication No. 86-23, 
revised 1985). Data and variables were compared by 
multiple analysis of variance to determine the effect of 
study groups and time points. Differences were considered 
significant atp < 0.05 by the Scheffe F test. All data in the 
text are presented as the mean + the standard eviation. 
Because two beagles receiving 3mg/kg injections and all 
receiving 4.5 mg/kg injections died of acute pulmonary 
edema within the first week of the DMCT administration, 
seven beagles receiving 1.5 mg/kg injections and eight 
receiving 4.5 injections were available for analysis. No 
significant differences were noted between the groups with 
respect to hemodynamic variables at baseline. The systolic 
pulmonary arterial pressure, mean pulmo~aary arterial 
pressure, and pulmonary vascular esistance in beagles 
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receiving 3 mg/kg injections significantly increased for 8 
weeks from 21 + 2 to 56 +- 9 mm Hg, 12 -+ 2 to 37 _+ 6 mm 
Hg, and 344 _ 130 to 2254 _+ 425 dyne-sec.cm 5, 
respectively. The cardiac output was significantly reduced 
from 1.6 -+ ,0.3 to 1.0 + 0.2 L/min in beagles receiving 3 
mg/kg injections. However, these changes in beagles re- 
ceiving 1.5 mg/kg injections were not so marked. The 
heart rate, mean arterial pressure, right atrial pressure, 
and pulmonary capillary wedge pressure remained rela- 
tively stable throughout he study period. The oxygen 
saturation significantly decreased from 99% + 1% to 
94% + 3% in beagles receiving 3 mg/kg injections. Gross 
pathologic evaluation revealed that the right ventricles 
were enlarged and the weight ratio of the right to left 
ventricle increased from 0.38 -+ 0.07 to 0.50 -+ 0.07 in 
beagles receiving 3 mg/kg injections. On histologic study, 
the right ventricular sections howed moderate myocyte 
hypertrophy and the thickness of the media in small 
pulmonary arteries was increased. Our data suggested that 
beagles treated with a 3.0 mg/kg injection of DMCT 
produced a unique, relatively noninvasive model of PH. 
There was a close correlation between the dose of DMCT 
and the severity of induced disease. 
Heart-lung transplantation has become a routine pro- 
cedure in the treatment of patients with end-stage PH. 
Recently, because of serious shortages of heart-lung 
blocks, single lung transplantation has been promoted as a 
possible alternative to heart-lung transplantation for end- 
stage pulmonary vascular disease of either primary or 
4s secondary causes." Despite clinical success with single 
lung transplants for PH, many problems remain to be 
solved. An interesting question is whether combined 
heart-lung, isolated single, or bilateral ung transplanta- 
tion would b,e preferable for the treatment of patients with 
PH. In clinical lung transplantation for end-stage pulmo- 
nary vascular disease, cardiopulmonary b pass is neces- 
sary during the procedure. Although lung transplantation 
in rats with PH has been investigated, rats are too small to 
be subjected to such circulatory assistance. For this reason 
a design for a new experimental model to induce PH in a 
larger animal is of vital importance for transplantation 
basal study. Furthermore, these relatively large animal 
models, in which hemodynamics an be measured accu- 
rately, are considered to be valuable for further studies 
not only on transplantation but also on pharmacology. We 
have now used this model to study relevant physiology and 
pathophysiology in PH and right ventricular function. 
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A TECHNIQUE TO MINIMIZE AIR LEAKAGE AFTER EXCISION OF EMPHYSEMATOUS BULLA OF 
THE LUNGS 
Iwao Takanami, MD, Yasuki Yamamoto, MD, Tatsuya Yamamoto, MD, and Susumu Kodaira, MD, Tokyo, Japan 
If pulmonary plication is done to treat an emphysema- 
tous bulla, pulmonary fistulae are sometimes formed and 
persist for long periods) We recently established a tech- 
nique to easily reduce postoperative air leakage with the 
use of bioabsorbable polyglactin 910 (Vicryl mesh; John- 
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son & Johnson Cardiovascular, King of Prussia, Pa.), a 
GIA 8 cm linear stapling device (United States Surgical 
Corporation, Auto Suture Company Division, Norwalk, 
Conn.), and fibrin glue (Bolheal; Teijin, Inc., Tokyo, Japan). 
Several strips of absorbable polyglactin 910 (1 cm wide 
and 8 cm long) were prepared. One of these strips was 
bonded by fibrin glue onto both sides of the GIA linear 
stapling device (the cartridge side and the front side) (Fig. 
1). The bulla was lifted by pulmonary forceps until it had 
a tentlike appearance. The stapling device to which strips 
of polyglactin 910 had been bonded was applied across the 
pulmonary base that was to be resected. The stapler was 
then used to resect he target tissue. In cases in which the 
